Article
NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's Ataxia.
JCI insight - 18 Jul 2024
Perry Caroline E, Halawani Sarah M, Mukherjee Sarmistha, Ngaba Lucie V, Lieu Melissa, Lee Won Dong, Davis James G, Adzika Gabriel K, Bebenek Alyssa N, Bazianos Daniel D, Chen Beishan, Mercado-Ayon Elizabeth, Flatley Liam P, Suryawanshi Arjun P, Ho Isabelle, Rabinowitz Joshua D, Serai Suraj D, Biko David M, Tamaroff Jaclyn, DeDio Anna, Wade Kristin, Lin Kimberly Y, Livingston David J, McCormack Shana E, Lynch David R, Baur Joseph A
Abstract excerpt
Friedreich's ataxia (FRDA) is a progressive disorder caused by insufficient expression of frataxin, which plays a critical role in assembly of iron-sulfur centers in mitochondria. Individuals are cognitively normal but display a loss of motor coordination and cardiac abnormalities. Many ultimately develop heart failure. Administration of nicotinamide adenine dinucleotide-positive (NAD+) precursors has shown...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
